Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 60 clinical trials
PGMP for Alberta Surgical Patients

Patients with postoperative hyperglycemia have higher complication rates and worse outcomes than patients with in-target glucose, including longer length-of-stay, more admissions to intensive care, increased readmission rates, and higher risk of infection. There are 35-40% of surgical patients at risk of postoperative hyperglycemia, including 20-30% of patients with diabetes, 10% …

Accepts healthy volunteers
  • 0 views
  • 27 May, 2022
  • 1 location
Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients (TGC-fast)

Critically ill patients usually develop hyperglycemia, which is associated with an increased risk of morbidity and mortality. Controversy exists on whether targeting normal blood glucose concentrations with insulin therapy, referred to as tight blood glucose control (TGC) improves outcome of these patients, as compared to tolerating hyperglycemia. It remains unknown …

critical illness
insulin
enteral nutrition
  • 7 views
  • 14 Feb, 2022
  • 4 locations
Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support

The objective of this study is to compare the effectiveness of a novel program-Family Partners for Health Action (FAM-ACT) - to individual patient-focused diabetes self-management education and care management(I-DSME/CM).

diabetes
  • 0 views
  • 25 Mar, 2022
  • 1 location
Early Detection Initiative for Pancreatic Cancer (EDI)

The Early Detection Initiative for Pancreatic Cancer is a multi-center randomized controlled trial to determine if algorithm-based screening in patients with new onset hyperglycemia and diabetes can result in earlier detection of pancreatic ductal adenocarcinoma.

cancer
fasting
hemoglobin a1c
hyperglycemia
glucose tolerance test
  • 0 views
  • 27 Apr, 2022
  • 2 locations
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec (COMBINE 1)

This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin icodec taken once a week in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar level in people with type …

  • 0 views
  • 20 Jun, 2022
  • 1 location
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) (COMBINE 2)

This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to semaglutide taken once a week in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar level in people with type 2 …

  • 0 views
  • 28 May, 2022
  • 4 locations
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) (REALYSE)

This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines used in this study are tablets which lower blood sugar in people with type 2 diabetes. The purpose of the study is to see how well RYBELSUS® is …

  • 0 views
  • 06 Apr, 2022
  • 15 locations
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin glargine taken daily with insulin aspart in people with type 2 diabetes.The study will look at how well IcoSema controls blood sugar level in people with type …

  • 0 views
  • 05 Apr, 2022
  • 58 locations
Effect of the Olive Leaf Tea Ingestion in Post-prandial Glycemic Response (OLIFTEA) (OLIFTEA)

This study tests the effect of Olive Tea Ingestion in ameliorating glycemic response after a high-glycemic meal

Accepts healthy volunteers
  • 0 views
  • 19 Jun, 2022
  • 1 location
The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients

This is an investigator-initiated, prospective, observational accuracy-study. The aim of the study is to test the feasibility, safety, and accuracy of a subcutaneous continuous glucose monitoring system (the Dexcom G6 glucose monitoring system) in critically ill patients. A total of 40 adult patients admitted to the intensive care unit requiring …

  • 0 views
  • 11 Mar, 2022
  • 1 location